Literature DB >> 19935034

Resolution of hypertension and proteinuria after preeclampsia.

Durk Berks1, Eric A P Steegers, Marek Molas, Willy Visser.   

Abstract

OBJECTIVE: To estimate the time required for hypertension and proteinuria to resolve after preeclampsia, and to estimate how this time to resolution correlates with the levels of blood pressure and proteinuria during preeclampsia and prolonging pregnancy after the development of preeclampsia.
METHODS: This is a historic prospective cohort study of 205 preeclamptic women who were admitted between 1990 and 1992 at the Erasmus MC Medical Centre, Rotterdam, The Netherlands. Data were collected at 1.5, 3, 6, 12, 18, and 24 months after delivery. Hypertension was defined as a blood pressure 140/90 mm Hg or higher or use of antihypertensive drugs. Proteinuria was defined as 0.3 g/d or more. Resolution of hypertension and proteinuria were analyzed with the Turnbull extension to the Kaplan-Meier procedure. Correlations were calculated with an accelerated failure time model.
RESULTS: At 3 months postpartum, 39% of women still had hypertension, which decreased to 18% at 2 years postpartum. Resolution time increased by 60% (P<.001) for every 10-mm Hg increase in maximal systolic blood pressure, 40% (P=.044) for every 10-mm Hg increase in maximal diastolic blood pressure, and 3.6% (P=.001) for every 1-day increase in the diagnosis-to-delivery interval. At 3 months postpartum, 14% still had proteinuria, which decreased to 2% at 2 years postpartum. Resolution time increased by 16% (P=.001) for every 1-g/d increase in maximal proteinuria. Gestational age at onset of preeclampsia was not correlated with resolution time of hypertension and proteinuria.
CONCLUSION: The severity of preeclampsia and the time interval between diagnosis and delivery are associated with postpartum time to resolution of hypertension and proteinuria. After preeclampsia, it can take up to 2 years for hypertension and proteinuria to resolve. Therefore, the authors suggest that further invasive diagnostic tests for underlying renal disease may be postponed until 2 years postpartum. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Year:  2009        PMID: 19935034     DOI: 10.1097/AOG.0b013e3181c14e3e

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  42 in total

1.  Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice.

Authors:  Ashley K Woods; Darren S Hoffmann; Christine J Weydert; Scott D Butler; Yi Zhou; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2010-11-15       Impact factor: 10.190

Review 2.  A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Donatella Spotti; Franca Giacchino; Rossella Attini; Monica Limardo; Stefania Maxia; Antioco Fois; Linda Gammaro; Tullia Todros
Journal:  J Nephrol       Date:  2017-04-22       Impact factor: 3.902

3.  Pre-eclampsia: proteinuria in pre-eclampsia-does it matter any more?

Authors:  Mark A Brown
Journal:  Nat Rev Nephrol       Date:  2012-08-21       Impact factor: 28.314

4.  Pregnancies complicated by preeclampsia and non-preeclampsia-related nephrotic range proteinuria.

Authors:  R A Brown; G J Kemp; S A Walkinshaw; Mlp Howse
Journal:  Obstet Med       Date:  2013-08-13

5.  Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia.

Authors:  L D Levine; C Nkonde-Price; M Limaye; S K Srinivas
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

Review 6.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

7.  Preeclampsia and ESRD: The Role of Shared Risk Factors.

Authors:  Andrea G Kattah; Dawn C Scantlebury; Sanket Agarwal; Michelle M Mielke; Walter A Rocca; Amy L Weaver; Lisa E Vaughan; Virginia M Miller; Tracey L Weissgerber; Wendy White; Vesna D Garovic
Journal:  Am J Kidney Dis       Date:  2016-10-01       Impact factor: 8.860

8.  Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study.

Authors:  Kamalan Jeevaratnam; Vishna Devi Nadarajah; John Paul Judson; Sivalingam Nalliah; Mohd Farouk Abdullah
Journal:  BMC Pregnancy Childbirth       Date:  2010-09-28       Impact factor: 3.007

9.  Postpartum persistent proteinuria after preeclampsia: a single-center experience.

Authors:  Selman Unverdi; Mevlut Ceri; Hatice Unverdi; Rahmi Yilmaz; Ali Akcay; Murat Duranay
Journal:  Wien Klin Wochenschr       Date:  2013-01-19       Impact factor: 1.704

10.  Urinary podocalyxin as a marker of preeclampsia in a Hispanic population.

Authors:  Ylbe Palacios de Franco; Karina Velazquez; Natalia Segovia; Carolina Acosta; Deborah Yanosky; Ylbe V Franco Palacios; Amanda Ramos; Carlos R Franco Palacios
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.